Doug Hampton

Cyltezo®, first and only FDA-approved Interchangeable biosimilar to Humira®, now commercially available in the U.S.

by

Cyltezo® (adalimumab-adbm) expands treatment options for patients across multiple chronic inflammatory diseases Cyltezo is the only adalimumab biosimilar with Phase III comparative clinical studies in rheumatoid arthritis, plaque psoriasis and Crohn’s disease RIDGEFIELD, Conn., July 1, 2023 /PRNewswire/ — Boehringer Ingelheim announced today that Cyltezo® (adalimumab-adbm), a U.S. Food and Drug Administration (FDA)-approved Interchangeable biosimilar to Humira® … Read more

AMA issues CPT III code for icometrix’ AI-related brain MRI quantification software

by

This first CPT III code for AI-supported brain MRI reading brings icometrix to the standard of care BOSTON and LEUVEN, Belgium , July 1, 2023 /PRNewswire/ — The American Medical Association (AMA) has issued a Current Procedural Terminology (CPT) code for icometrix’ FDA-cleared, AI-related brain MRI quantification software, thereby creating a path to reimbursement.  The American … Read more

Marler Clark Files the Second Case in National Cyclospora Outbreak

by

Food Poisoning Sickens 210 in 22 States RIDGWAY, Colo., June 30, 2023 /PRNewswire/ — The Cyclospora attorneys at Marler Clark have filed the second lawsuit in a nationwide Cyclospora outbreak that has sickened 210 individuals in 22 states.  The lawsuit was filed on behalf of Patricia Pitts against Taco del GNAR, in the District Court … Read more

Cognitive depression, a new disorder defined by researchers

by

It was defined by researchers at Stanford University, and it concerns no less than one in four patients. As we already know, depression comes in several forms: postpartum after childbirth, chronic depressive disorder, to name but a few. But researchers at Stanford University have determined a new genus, called cognitive depression. Cognitive depression: the basis … Read more

Aethlon Medical Announces Fiscal Year End Financial Results and Provides Corporate Update

by

Conference Call to be Held Today at 4:30pm ET SAN DIEGO, June 28, 2023 /PRNewswire/ — Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life threatening infectious diseases, today reported financial results for its fiscal year ended March 31, 2023 and provided an update on recent … Read more

INTERVIEW. “Borderline personality disorder is the most common personality disorder”, explains Dr Anjali Mathur, head of the Bordelink unit

by

the essential Since last January, a new care unit specially dedicated to people suffering from borderline personality disorder has opened at the Toulouse University Hospital. The Borderlink team offers group psychotherapy to help these patients manage their hyperemotivity. Doctor Anjali Mathur, psychiatrist at Toulouse University Hospital, is responsible for the Borderlink care unit. She explains … Read more